GB1357121A - Peptide enzyme inhibitors - Google Patents
Peptide enzyme inhibitorsInfo
- Publication number
- GB1357121A GB1357121A GB1104871A GB1104871A GB1357121A GB 1357121 A GB1357121 A GB 1357121A GB 1104871 A GB1104871 A GB 1104871A GB 1104871 A GB1104871 A GB 1104871A GB 1357121 A GB1357121 A GB 1357121A
- Authority
- GB
- United Kingdom
- Prior art keywords
- asn
- peptides
- pro
- iii
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 239000002532 enzyme inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 102000015427 Angiotensins Human genes 0.000 abstract 1
- 108010064733 Angiotensins Proteins 0.000 abstract 1
- 239000002250 absorbent Substances 0.000 abstract 1
- 230000002745 absorbent Effects 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- -1 amino, guanidino Chemical group 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000007790 solid phase Substances 0.000 abstract 1
- 238000010561 standard procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06156—Dipeptides with the first amino acid being heterocyclic and Trp-amino acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5868670A | 1970-07-28 | 1970-07-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1357121A true GB1357121A (en) | 1974-06-19 |
Family
ID=22018295
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1104871A Expired GB1357121A (en) | 1970-07-28 | 1971-04-23 | Peptide enzyme inhibitors |
| GB2179473A Expired GB1357122A (en) | 1970-07-28 | 1971-04-23 | Polypeptide intermediates |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB2179473A Expired GB1357122A (en) | 1970-07-28 | 1971-04-23 | Polypeptide intermediates |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPS546556B1 (enExample) |
| CA (1) | CA946837A (enExample) |
| CH (1) | CH543483A (enExample) |
| DE (1) | DE2124451C3 (enExample) |
| FR (1) | FR2100959B1 (enExample) |
| GB (2) | GB1357121A (enExample) |
| HU (1) | HU164325B (enExample) |
| IE (1) | IE35074B1 (enExample) |
| NL (1) | NL165655C (enExample) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0979829A3 (de) * | 1998-08-13 | 2000-03-01 | Beiersdorf Aktiengesellschaft | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Oligopeptiden zur Hautaufhellung von Altersflecken bzw. zur Verhinderung der Hautbräunung, insbesondere der durch UV-Strahlung hervorgerufenen Hautbräunung |
| WO2006105805A1 (en) * | 2005-04-07 | 2006-10-12 | Miso Sabovic | Delaying skin ageing and disorders caused by skin ageing by suppression of angiotensin ii production or activity |
| WO2009058244A1 (en) * | 2007-10-29 | 2009-05-07 | Helix Biomedix Inc. | Protective skin care tetrapeptides |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4108886A (en) * | 1977-03-11 | 1978-08-22 | E. R. Squibb & Sons, Inc. | Thiopropanoylamino acid derivatives |
-
1971
- 1971-04-23 CA CA111,193A patent/CA946837A/en not_active Expired
- 1971-04-23 GB GB1104871A patent/GB1357121A/en not_active Expired
- 1971-04-23 GB GB2179473A patent/GB1357122A/en not_active Expired
- 1971-04-27 IE IE52471A patent/IE35074B1/xx unknown
- 1971-05-17 DE DE19712124451 patent/DE2124451C3/de not_active Expired
- 1971-05-18 HU HUSU000623 patent/HU164325B/hu unknown
- 1971-06-18 NL NL7108452A patent/NL165655C/xx not_active IP Right Cessation
- 1971-07-05 CH CH985371A patent/CH543483A/fr not_active IP Right Cessation
- 1971-07-20 JP JP5413171A patent/JPS546556B1/ja active Pending
- 1971-07-27 FR FR7127504A patent/FR2100959B1/fr not_active Expired
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0979829A3 (de) * | 1998-08-13 | 2000-03-01 | Beiersdorf Aktiengesellschaft | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Oligopeptiden zur Hautaufhellung von Altersflecken bzw. zur Verhinderung der Hautbräunung, insbesondere der durch UV-Strahlung hervorgerufenen Hautbräunung |
| US6852699B1 (en) | 1998-08-13 | 2005-02-08 | Beiersdorf Ag | Cosmetic or dermatological preparations comprising oligopeptides for lightening the skin of age marks and/or for preventing tanning of the skin, in particular tanning of the skin caused by uv radiation |
| US7498310B1 (en) | 1998-08-13 | 2009-03-03 | Beiersdorf Ag | Cosmetic or dermatological preparations comprising oligopeptides for lightening the skin of age marks and/or for preventing tanning of the skin, in particular tanning of the skin caused by UV radiation |
| WO2006105805A1 (en) * | 2005-04-07 | 2006-10-12 | Miso Sabovic | Delaying skin ageing and disorders caused by skin ageing by suppression of angiotensin ii production or activity |
| WO2009058244A1 (en) * | 2007-10-29 | 2009-05-07 | Helix Biomedix Inc. | Protective skin care tetrapeptides |
| US8071555B2 (en) | 2007-10-29 | 2011-12-06 | Helix Biomedix Inc. | Protective skin care peptides |
| CN101855235B (zh) * | 2007-10-29 | 2013-04-24 | 赫里克斯生物医疗公司 | 保护性皮肤护理四肽 |
Also Published As
| Publication number | Publication date |
|---|---|
| IE35074B1 (en) | 1975-10-29 |
| NL165655B (nl) | 1980-12-15 |
| CA946837A (en) | 1974-05-07 |
| CH543483A (fr) | 1973-10-31 |
| FR2100959A1 (enExample) | 1972-03-24 |
| DE2124451A1 (de) | 1972-02-24 |
| NL165655C (nl) | 1981-05-15 |
| DE2124451C3 (de) | 1980-09-18 |
| NL7108452A (enExample) | 1972-02-01 |
| JPS546556B1 (enExample) | 1979-03-29 |
| GB1357122A (en) | 1974-06-19 |
| IE35074L (en) | 1972-01-28 |
| DE2124451B2 (de) | 1979-11-29 |
| FR2100959B1 (enExample) | 1974-09-06 |
| HU164325B (enExample) | 1974-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yeoman et al. | Amino acid sequence of the center of the arginine-lysine-rich histone from calf thymus: the total sequence | |
| PT93245B (pt) | Processo para a preparacao de novos derivados de glicina e de composicoes farmaceuticas que os contem | |
| JPS59500863A (ja) | ゴナドリベリン誘導体、その製造方法及びその医薬及び獣医薬組成物 | |
| EE03180B1 (et) | Bombesiini antagonistpeptiidid, farmatseutiline kompositsioon ja kasutamine | |
| US3920627A (en) | Position 1 analogs of {8 phenylglycyl{9 -angiotension II | |
| EP0333071A2 (en) | Polypeptides, methods for their preparation, pharmaceutical compositions comprising them and use | |
| GB1357121A (en) | Peptide enzyme inhibitors | |
| Li et al. | The Synthesis of L-Histidyl-L-phenylalanyl-L-ornithyl-L-tryptophyl-glycine and L-Histidyl-D-phenylalanyl-L-ornithyl-L-tryptophyl-glycine and their Melanocyte-stimulating Activity | |
| JPH09507213A (ja) | 抗血栓性アザシクロアルキルアルカノイルペプチド及びプソイドペプチド | |
| GB1281383A (en) | Sulphonated peptides and their production | |
| GB1491017A (en) | Peptides | |
| US3873511A (en) | (1-{60 -Aminoisobutyric acid)-corticotropin peptides | |
| US4203975A (en) | Psychopharmacological peptides suitable for therapeutic administration | |
| GB1536878A (en) | Octapeptide | |
| EP0161017A1 (en) | Peptides | |
| GB1002041A (en) | New polypeptides and process for their manufacture | |
| DE3476666D1 (en) | Novel peptide, process for the preparation thereof and pharmaceutical composition containing said peptide | |
| JP2628199B2 (ja) | 新規なアシルアミノ酸およびアシルペプチド化合物 | |
| Matsumura et al. | Degradation pathway of kinins in tumor ascites and inhibition by kininase inhibitors: analysis by HPLC | |
| GB1346317A (en) | Peptide enzyme inhibitor | |
| US3790555A (en) | Octapeptide derivative of gonadotropinreleasing hormone | |
| GB1273873A (en) | Corticotropically highly active octadecapeptides | |
| US3738978A (en) | Process for the manufacture of peptides | |
| US6274705B1 (en) | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides | |
| KR930012034A (ko) | 급성 췌장염 치료용 브래디키닌-길항제 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PE20 | Patent expired after termination of 20 years |